CNS Regeneration 2008
DOI: 10.1016/b978-012373994-0.50011-7
|View full text |Cite
|
Sign up to set email alerts
|

Direct Delivery of GDNF Into the Non-Human Primate and Human Parkinsonian Brain: Success and Road Blocks

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2008
2008
2008
2008

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 56 publications
0
2
0
Order By: Relevance
“…Several factors have been shown to produce significant beneficial effects in the laboratory [81]. Only glial cell line-derived neurotrophic factor (GDNF) has been shown to dramatically protect and enhance the function of dopamine neurons in animal models of PD [82]- [84].…”
Section: A Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Several factors have been shown to produce significant beneficial effects in the laboratory [81]. Only glial cell line-derived neurotrophic factor (GDNF) has been shown to dramatically protect and enhance the function of dopamine neurons in animal models of PD [82]- [84].…”
Section: A Introductionmentioning
confidence: 99%
“…The biologically active form is a glycosylated homodimer of kDa [86]. This section is a review of studies carried out in a nonhuman primate model of PD and in humans with PD involving site-specific delivery of GDNF by computer-controlled pumps coupled to infusion catheters [84]. While this work focuses on studies of GDNF and its potential use in treating PD, these studies lay the foundation for the site-specific delivery of many drugs to the brain that may be beneficial for treatment of neurodegenerative diseases and brain disorders.…”
Section: A Introductionmentioning
confidence: 99%